Diabetes and Ramadan: Utility of flash-glucose monitoring derived markers of glycaemic control and comparison with glycosylated haemoglobin

      Abstract

      Aims

      Flash glucose monitoring (FGM)-derived markers of glucose control and variability and laboratory measured HbA1c among patients with diabetes on insulin in context of Ramadan fasting (RF) were examined and compared.

      Methods

      FGM data on insulin-treated patients (n = 20, age 42.3 ± 11.4 years; 18 male, 2 female; 13 with type 1 and 7 with type 2 diabetes) who fasted during Ramadan were used to calculate Q-score as an indicator of glycaemia before, during and after RF. Post-hoc analysis in a group of patients (n = 12) who had HbA1c available and appropriate for these periods was performed. Other relevant data were extracted from patient records.

      Results

      Mean glucose (9.6 ± 1.32 v 10.78 ± 1.64 mmol/l; P < 0.0001) and Q-score increased significantly with Ramadan fasting and reduced after Ramadan. Post-hoc subgroup analysis showed a significant rise in eA1c (7.2 ± 0.4%; 55.0 ± 4.4 mmol/mol v 7.7 ± 0.5%; 61.0 ± 5.5 mmol/mol) but not in laboratory HbA1c with Ramadan fasting; eA1c reduced after Ramadan (P = 0.018).

      Conclusions

      Ramadan fasting was associated with a deterioration in overall glucose control and time in hyperglycaemia in insulin-treated patients. FGM-derived markers are useful and a preferable alternative to HbA1c in Ramadan studies.
      To read this article in full you will need to make a payment

      References

        • Hakeem R.
        • et al.
        Dietary patterns and glycemic control and compliance to dietary advice among fasting patients with diabetes during Ramadan.
        Diabet Care. 2014; 37: e47-e48
        • Reilly T.
        • Waterhouse J.
        Altered sleep–wake cycles and food intake: the Ramadan model.
        Physiol Behav. 2007; 90: 219-228
        • Hassanein M.
        • et al.
        Diabetes and Ramadan: practical guidelines.
        Diabet Res Clin Pract. 2017; 126: 303-316
        • Ahmad J.
        • et al.
        Diabetic emergencies including hypoglycemia during Ramadan.
        Indian J Endocrinol Metabolism. 2012; 16: 512
        • Afandi B.
        • et al.
        Rate, Timing, and Severity of hypoglycemia in adolescents with Type 1 diabetes during ramadan fasting: a study with freestyle libre flash glucose monitoring system.
        Ibnosina J Med Biomed Sci. 2018; 10: 9
        • Abid M.
        • et al.
        survey on diabetic patients treated with insulin during the fasting month of ramadan.
        Int J General Med. 2018; 11: 33
        • Salti I.
        • et al.
        A population-based study of diabetes and its characteristics during the fasting month of Ramadan in 13 countries: results of the epidemiology of diabetes and Ramadan 1422/2001 (EPIDIAR) study.
        Diabet Care. 2004; 27: 2306-2311
        • John W.G.
        Glycated haemoglobin analysis.
        Ann Clin Biochem. 1997; 34: 17-31
        • Jeffcoate S.L.
        Diabetes control and complications: the role of glycated haemoglobin, 25 years on.
        Diabet Med. 2004; 21: 657-665
        • Association 2 A.D.
        Classification and diagnosis of diabetes: standards of medical care in diabetes—2019.
        Diabet Care. 2019; 42: S13-S28
        • Jabbar A.
        • et al.
        CREED study: Hypoglycaemia during Ramadan in individuals with Type 2 diabetes mellitus from three continents.
        Diabet Res Clin Pract. 2017; 132: 19-26
        • Sherwani S.I.
        • et al.
        Significance of HbA1c test in diagnosis and prognosis of diabetic patients.
        Biomark Insights. 2016; 11: 95-104
        • Siaw M.Y.L.
        • et al.
        Evaluating the effect of Ramadan fasting on muslim patients with diabetes in relation to use of medication and lifestyle patterns: a prospective study.
        Int J Endocrinol 2014. 2014;
        • Gustaviani R.
        • et al.
        The influence of calorie restriction during the Ramadan fast on serum fructosamine and the formation of beta hydroxybutirate in type 2 diabetes mellitus patients.
        Acta Med Indones. 2004; 36: 136-141
        • Danese E.
        • et al.
        Advantages and pitfalls of fructosamine and glycated albumin in the diagnosis and treatment of diabetes.
        J Diabet Sci Technol. 2015; 9: 169-176
        • Kaplan W.
        • Afandi B.
        Blood glucose fluctuation during Ramadan fasting in adolescents with type 1 diabetes: findings of continuous glucose monitoring.
        Diabet Care. 2015; 38: e162-e163
        • Afandi B.
        • et al.
        Correlation between pre-ramadan glycemic control and subsequent glucose fluctuation during fasting in adolescents with Type 1 diabetes.
        J Endocrinol Invest. 2017; 40: 741-744
        • Al-Agha A.E.
        • et al.
        Flash glucose monitoring system may benefit children and adolescents with type 1 diabetes during fasting at Ramadan.
        Saudi Med J. 2017; 38: 366
        • Lessan N.
        • et al.
        Glucose excursions and glycaemic control during Ramadan fasting in diabetic patients: insights from continuous glucose monitoring (CGM).
        Diabet Metab. 2015; 41: 28-36
        • Joubert M.
        • et al.
        Indication, organization, practical implementation and interpretation guidelines for retrospective CGM recording: a French position statement.
        Diabet Metabolism. 2015; 41: 498-508
        • Hirsch I.B.
        Professional flash continuous glucose monitoring as a supplement to A1C in primary care.
        Postgrad Med. 2017; 129: 781-790
        • Bashir M.
        • et al.
        A pilot study using flash continuous glucose monitoring in patients with type-2 diabetes on multiple anti-diabetic agents during Ramadan.
        Diabet Metab Syndr. 2018; 12: 965-968
        • Zabeen B.
        • et al.
        Fasting during Ramadan in adolescents with diabetes.
        Indian J Endocrinol Metabolism. 2014; 18: 44
        • Ahmedani M.Y.
        • et al.
        Implementation of Ramadan-specific diabetes management recommendations: a multi-centered prospective study from Pakistan.
        J Diabet Metabolic Disord. 2014; 13: 37
        • Bergenstal R.M.
        • et al.
        Glucose Management Indicator (GMI): a new term for estimating A1C from continuous glucose monitoring.
        Diabet Care. 2018; 41: 2275-2280
        • Augstein P.
        • et al.
        Q-Score: development of a new metric for continuous glucose monitoring that enables stratification of antihyperglycaemic therapies.
        BMC Endocr Disord. 2015; 15: 22
        • Bailey T.
        • et al.
        The performance and usability of a factory-calibrated flash glucose monitoring system.
        Diabet Technol Ther. 2015; 17: 787-794
        • Danne T.
        • et al.
        International consensus on use of continuous glucose monitoring.
        Diabet Care. 2017; 40: 1631-1640
        • Bergenstal R.M.
        • et al.
        Glucose management indicator (GMI): a new term for estimating A1C from continuous glucose monitoring.
        Diabet Care. 2018; 41: 2275-2280
        • Norouzy A.
        • et al.
        Effect of Ramadan fasting on glycemic control in patients with type 2 diabetes.
        J Endocrinol Invest. 2012; 35: 766-771
        • Mafauzy M.
        • et al.
        A study of the fasting diabetic patients during the month of Ramadan.
        Med J Malaysia. 1990; 45: 14-17
        • Inchiostro S.
        • Candido R.
        • Cavalot F.
        How can we monitor glycaemic variability in the clinical setting?.
        Diabet Obes Metab. 2013; 15: 13-16
        • Bonakdaran S.
        • Rajabian R.
        Prevalence and extent of glycemic excursions in well-controlled patients with type 2 diabetes mellitus using continuous glucose-monitoring system.
        Indian J Med Sci. 2009; 63: 66-71
        • Kaplan W.
        • et al.
        Comparison of continuous glucose monitoring in adolescents with type 1 diabetes: Ramadan versus non-Ramadan.
        Diabet Res Clin Pract. 2017; 134: 178-182
        • Rodbard D.
        Continuous glucose monitoring: a review of recent studies demonstrating improved glycemic outcomes.
        Diabetes Technol Ther. 2017; 19: S25-S37
        • Carlson A.L.
        • Mullen D.M.
        • Bergenstal R.M.
        Clinical use of continuous glucose monitoring in adults with type 2 diabetes.
        Diabet Technol Ther. 2017; 19: S4-s11
        • Lessan N.G.
        • et al.
        Glycemic patterns detected by CGMS in patients with diabetes mellitus in the United Arab Emirates.
        Diabet Technol Ther. 2006; 8: 513-515